OMIC
ESPR

Old Mission Investment Co’s Esperion Therapeutics ESPR Stock Holding History

Old Mission Investment Co’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,100
Closed -$227K – 107
2021
Q1 		$227K Hold
8,100
– – 0.11% 97
2020
Q4 		$211K Hold
8,100
– – 0.11% 87
2020
Q3 		$301K Hold
8,100
– – 0.18% 69
2020
Q2 		$416K Buy
8,100
+25
+0.3% +$1.05K 0.29% 49
2020
Q1 		$255K Buy
+8,075
New +$426K 0.24% 61

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Old Mission Investment Co's ESPR Position: Q2 2021 in Review

Old Mission Investment Co sold out of Esperion Therapeutics (ESPR) in Q2 2021, closing a stake of 8,100 shares — an estimated $227K sold.

Old Mission Investment Co first reported a position in ESPR in Q1 2020 and held it in 5 quarters. The position peaked at $416K in Q2 2020. 142 funds tracked by Wall St. Rank hold ESPR as of Q2 2021.

  • Old Mission Investment Co reported no remaining Esperion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Old Mission Investment Co sold 8,100 Esperion Therapeutics shares in Q2 2021, an estimated $227K.
  • Old Mission Investment Co first reported a position in Esperion Therapeutics in Q1 2020 and held it in 5 quarters.
  • Old Mission Investment Co's Esperion Therapeutics position peaked at $416K in Q2 2020.
  • 142 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2021.

Based on Old Mission Investment Co's 13F filing for Q2 2021, filed 16 Sep 2026.